OQROSign up free
Fund moves

Jade Biosciences (JBIO): Frazier Life Sciences Management, L.P. opened a new position $17.7M

Frazier Life Sciences Management, L.P. opened a new position in Jade Biosciences, per its Q2 2025 13F.

1.77M
Shares reported
0.71%
Disclosed portfolio weight
$17.7M
Reported value
Holdings as of
Jun 30, 2025
Filed
Aug 14, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

    What came next

    1. Sep 5, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“Effective September 9, 2025, Hetal Kocinsky, M.D. departed from her position as Chief Medical Officer of Jade Biosciences, Inc. (the “Company”). The Company expects to enter into a separation agreement with Dr. Kocinsky.”
    2. Oct 3, 2025Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
    3. Nov 13, 2025Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
    View the official recordSEC Form 13F-HR

    How to read SEC Form 13F-HR

    Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

    Full guide: What is an SEC Form 13F?

    What else is on file for Jade Biosciences

    For Jade Biosciences, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

    These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JBIO page.

    How this filing works

    Explore the data

    Other disclosures at Jade Biosciences

    Everything OQRO holds on this company is on its JBIO page.

    This is one filing. OQRO holds the rest

    Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

    Sign up freeAlready have an account? Log in

    OQRO is free for everyone. No card, no trial

    OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data